The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Alcon Inc.  (ACL) Trade Now »     Rate ACL  -  Discuss ACL  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Major Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
88.0%
Top:
100.0%
Rate ACL:



ACL Analysis & Videos »


ACL: Bull or Bear?

Expanding Defensive Growth Index into Europe Graphic_rating_buy ACL
Mikerun
73%
 +42.06%
in 384 days

Expanding Defensive Growth Index into Europe

<>
<> The accompanying table presents an updated version of the ETFI Highly Defensive PerformIdex, which is expanded to 40 companies with market caps of at least $10B from the industry groups listed below. This defensive growth index is heavily weighted in consumer staples and healthcare and is now structured to include companies based in Europe, in addition to the United States and Canada.

Compared to the previous version, this index has a lower beta and higher average market cap and adds European companie...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/22/08 Comment


ACL Pipeline Better in Long-Term ACL
-8.58%
in 501 days
The lofty valuation the shares trade at likely leaves little room for significant appreciation in the near term.
By  Zacks.com   (-14.33%  risk: moderate)  06/27/08 Comment


Alcon (ACL): An eye on world's largest eye care firm Graphic_rating_buy ACL
16%
 -6.34%
in 526 days

"You may not have your eye on Alcon (NYSE: ACL)," notes global expert Frida Ghitis, adding, "But if you wear contact lenses, suffer from dry eyes, worry about glaucoma, or even if you have hay-fever, you may have bought its products."

Here, the contributing advisor to Vivian Lewis' Global Investing, explains, "This Swiss eye drug giant has its eyes on both the bottom line and its pipeline."

<>"As the world’s largest eye care company, ALC has excellent management, stellar performance, promising demographics, and an intriguing ownership structure.
 
"Demographics bode well. Aging eyes need att...
By  The Stock Advisors   (-18.08%  risk: moderate)  06/02/08 Comment


Get free stock alert for ACL:
Your Email Address:


Keep an eye on Alcon (ACL) Graphic_rating_buy ACL
-6.33%
in 525 days

Filed under: International markets, Newsletters, Stocks to Buy

"You may not have your eye on Alcon Inc. (NYSE: ACL), but if you wear contact lenses, suffer from dry eyes, worry about glaucoma, or even if you have hay-fever, you may have bought ACL products," notes global expert Frida Ghitis.

Here, the contributing advisor to Vivian Lewis' Global Investing, explains, "This Swiss eye drug giant has with its eyes on both the bottom line and the pipeline.

<>"As the world's largest eye care company, ALC has excellent management, stellar performance, promising demographics, and an intriguing ownershi...
By  Steven Halpern   (+4.67%  risk: moderate)  06/03/08 Comment


Excellent play on baby boomers getting older Graphic_rating_buy ACL
37%
 +5.24%
in 933 days
Alcon is the dominant player in the opthalmic market including drugs, devices, and over the counter eyecare products.  As the boomers get older, they'll start going blind.

They also can benefit from the emerging markets getting wealthier so that their people with bad eyesight can start affording these treatments.
By  publius72   (-8.73%  risk: aggressive)  04/22/07 Comment


Alcon (ACL) Graphic_rating_buy ACL
Robertfreedlandphoto
36%
 +13.33%
in 999 days
I was looking through the list of top % gainers on the NYSE this evening and came across Alcon, ACL, which closed at $129.77, up $9.02 or 7.47% on the day. I do not own any shares of Alcon, but my son does own 5 shares in an account that I monitor. I believe this company deserves a spot on my blog so let me go over a few of the points that I think justifies its inclusion here....
...Taking into consideration my son's small investment in this stock, I have a small bias towards the stock. However, seriously, the stock traded nicely today in an otherwise weak market. The latest quarterly r...
By  Robert Freedland   (-5.24%  risk: aggressive)  02/15/07 1 comment





People Bullish on ACL

Ace_spades
jonock
Analyst
N/A
27 days ago

pengar
Analyst
N/A
3 mos ago

Foto
Marian Filo
Principal
62%
4 mos ago

william0509
Associate
67%
6 mos ago

jrimbey
Analyst
79%
10 mos ago


People Bearish on ACL

Art
Analyst
N/A
11 mos ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.57% 370
2 Gerald Greene 18.14 +68.57% 207
3 stockmarketfunding.com 17.66 +25.68% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +77.15% 34


POPULAR STOCKS
Symbol Company Name Sentiment
AMZN Amazoncom Inc
WM Washington Mutual Inc
GS Goldman Sachs Group Inc The
PG The Procter & Gamble Company
FNM Fannie Mae
ETFC E*Trade Financial Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on ACL


Discussion Wall + Add  
amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies

amritadas   (+0.00%)
a
+   0 replies

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies


More Resources

Graphic_arrow1 About Alcon Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch